Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
Supporting Files
Public Domain
-
5 2022
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:To determine neutralizing activity against the severe acute respiratory syndrome coronavirus 2 ancestral strain and 4 variants of concern, we tested serum from 30 persons with breakthrough infection after 2-dose vaccination. Cross-variant neutralizing activity was comparable to that after 3-dose vaccination. Shorter intervals between vaccination and breakthrough infection correlated with lower neutralizing titers.
-
Subjects:
-
Source:Emerg Infect Dis. 2022; 28(5):1050-1052
-
Pubmed ID:35259088
-
Pubmed Central ID:PMC9045428
-
Document Type:
-
Genre:
-
Volume:28
-
Issue:5
-
Collection(s):
-
Main Document Checksum:urn:sha256:d1ea788dab9a78c6906e068a9e619a5d9acbd50d211264410fa1f271f1473863
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases